庄辉院士:为什么指南不推荐TAF预防HBV母婴传播( 三 )


15.ZengQL,ZhangHX,ZhangJY,etal.TenofoviralafenamideforpregnantChinesewomenwithactivechronichepatitisB:Amulticenterprospectivestudy.ClinGastroenterolHepatol,2022,20(12):2826-2837.e9.
16.DingY,CaoL,ZhuL,etal.Efficacyandsafetyoftenofoviralafenamidefumarateforpreventingmother-to-childtransmissionofhepatitisBvirus:anationalcohortstudy.AlimentPharmacolTher,2020,52(8):1377-1386.
17.HanG,ZhouG,SunT,etal.Tenofoviralafenamideinblockingmother-to-childtransmissionofhepatitisBvirus:amulti-center,prospectivestudy.JMaternFetalNeonatalMed,2022,1-8.
#****#3往期推荐
肝病年会丨庄辉院士:中国肝病的疾病负担
肝病年会丨韩涛教授:肝衰竭诊治的进展与挑战
肝病年会丨范建高教授:《肝硬化合并糖尿病患者血糖管理专家共识》解读
肝病年会丨《慢性乙型肝炎防治指南(2022年版)》更新要点详解返回搜狐 , 查看更多
责任编辑: